2020-2021 NAVY INFLUENZA VACCINATION AND REPORTING POLICY:
R 211525Z SEP 20 MID510001736816U
FM CNO WASHINGTON DC
INFO CNO WASHINGTON DC
MSGID/GENADMIN/CNO WASHINGTON DC//
SUBJ/2020-2021 NAVY INFLUENZA VACCINATION AND REPORTING POLICY//
REF/C/DOC/32 CFR PART 199.21/1DEC2016//
NARR/REF A IS THE DEFENSE HEALTH AGENCY PROCEDURAL INSTRUCTION 6025.34
GUIDANCE FOR THE DOD INFLUENZA VACCINATION PROGRAM (IVP).
REF B IS THE DODI 6025.02 INDIVIDUAL MEDICAL READINESS ADDRESSING
RESPONSIBILITIES AND PROCEDURES FOR MONITORING AND ON INDIVIDUAL MEDICAL
REF C IS 32 CFR PART 199.21, CIVILIAN HEALTH AND MEDICAL PROGRAM OF THE
UNIFORMED SERVICES (CHAMPUS)/TRICARE: TRICARE PHARMACY BENEFITS PROGRAM.//
POC/LCDR MATTHEW HALL/BUMED M4/(703) 681-9120/EMAIL:
RMKS/1. Influenza or "flu" has the potential to adversely impact Navy force
readiness and mission execution. The Centers for Disease Control and
Prevention (CDC) believes it is likely that influenza viruses and the virus
that causes COVID-19 will be circulating this coming fall and winter. In this
context, getting an influenza vaccination will be more important than ever.
2. Influenza Vaccination and Reporting
a. Influenza Disease Prevention. Vaccination is the primary method to
reduce the risk of influenza by enhancing force immunity. Maintaining a
clean work environment, practicing good hygiene, and managing workforce
exposure (e.g., social distancing, teleworking, and sick leave) are effective
methods to reduce the risk of spreading influenza.
b. Influenza Vaccine. Two influenza vaccines, Northern Hemisphere (NH)
and Southern Hemisphere (SH), are available based on service member location
and timing requirements, as described in reference (a). The 2020-2021
Department of Defense (DoD) influenza vaccine supply will be comprised of
injectable vaccines. Intranasal vaccine will not be provided through the
central ordering process.
c. Influenza Vaccine Priority. U.S. Navy ships, operational assets, and
training commands have been identified by the DoD and the Department of the
Navy (DON) as vaccine priority groups for the 2020-2021 influenza season.
d. Influenza Vaccine Ordering. The DON influenza vaccine is centrally
funded. The Vaccine Information and Logistics System (VIALS) is the online
requisition system for the seasonal influenza vaccine. VIALS electronically
tracks requisitioned vaccine via Military Standard Requisitioning and Issuing
Procedure (MILSTRIP) from requisition to receipt. The VIALS Web site is
common access card enabled:
e. The Naval Medical Logistics Command (NAVMEDLOGCOM) is responsible for
ordering and distributing influenza vaccine for all Navy and Marine Corps
activities. Additional quantities required and/or changes in submitted
orders must be coordinated with the NAVMEDLOGCOM Influenza Vaccine Manager,
DSN: (312) 343-8054 or the Vaccine Information and Logistics System (VIALS)
helpdesk at: firstname.lastname@example.org.
f. Influenza Vaccine Shipping. All commands will verify their correct
shipping address and point of contact information in VIALS to ensure prompt
g. Influenza Vaccine Integrity. (Temperature Monitors). All Influenza
vaccine shipments include temperature monitors. All monitors must be
returned to the Defense Logistics Agency Troop Support Medical (DLA-TSM) cold
chain office after receipt, per the included instructions and shipping
materials, and must comply with the following guidance regarding use of those
(1) No Alarm Status. The doses are ready for immediate use.
(2) Alarmed Status. Do not administer those doses. Segregate them
in an appropriate vaccine storage refrigerator, clearly label "DO NOT USE,"
immediately return temperature monitor to DLA-TSM, and await DLAs disposition
of those doses.
h. Influenza Vaccine Exercise
(1) During previous influenza seasons, exercises have been used to
evaluate mass vaccination scenarios while accomplishing vaccine distribution.
These coordinated mass vaccination campaigns provide rapid and efficient
vaccinations to protect the maximum number of susceptible persons. Process
improvements are made to delivery and reporting procedures based on lessons
learned. Ensure masking, social distancing, group size limitations, and
other appropriate precautions during any mass vaccination exercises, if
The Seasonal Influenza Resource Center 2020-21 available via
Resource-Center contains different resources for the 2020-21 influenza
(2) Installations and Medical Treatment Facilities (MTFs) may also
consider using the Navy Family Accountability and Assessment System (NFAAS)
to conduct a Pandemic Influenza response exercise in conjunction with the
seasonal influenza vaccine program.
(3) Vaccine Delivery. Due to vaccine demand and manufacturer
limitations, complete vaccine delivery may not occur until mid-
November. This delay will unintentionally test the ability to conduct rapid
and complete mass vaccination exercises.
i. Influenza Vaccination Compliance
(1) Navy Military Personnel. The seasonal influenza vaccination is
mandatory for all DoD uniformed personnel who are not medically or
administratively exempt, per references (a) and (b). Any refusal to receive
the influenza vaccine will constitute a failure to obey a lawful order and
may be punishable under the Uniform Code of Military Justice and/or result in
administrative action. Prior to receiving the influenza vaccine, Navy Active
and Reserve Component personnel will have access to healthcare providers to
address questions or concerns with influenza vaccination. Commands must
consult with the servicing Staff Judge Advocate General and cognizant
Preventive Medicine authority for additional guidance on influenza
(2) Navy Civilian Personnel. Influenza vaccination is required for
all civilian healthcare personnel, per reference (a), and is strongly
encouraged for all other Navy civilian employees.
(3) TRICARE Beneficiaries. Reference (c) authorizes retail network
pharmacies to administer the seasonal influenza vaccine. TRICARE
beneficiaries may receive influenza vaccinations with no co-pay at authorized
retail network pharmacies. Beneficiaries are encouraged to contact the
pharmacy regarding age restrictions as some pharmacies do not administer the
influenza vaccine to individuals younger than 18 years of age.
j. Influenza Vaccination Reporting. All influenza vaccinations of
Service Members shall be documented in the Medical Readiness Reporting System
(MRRS) as well as the Electronic Health Record (EHR). Active and Reserve
Component Navy influenza vaccination administration will be monitored via
MRRS. Designated command personnel will access MRRS to track their personnel
to ensure compliance. Civilian vaccination administration compliance will be
monitored and tracked via AHLTA and/or other electronic tracking.
(1) Shore-based commands will request access to MRRS based on their
unit identification code by submitting a system access authorization request
available at: //mrrs.dc3n.navy.mil/mrrs (note: MRRS Web address is case
Point of contact: MRRS program office and e-mail: email@example.com
(800) 537-4617/(504) 697-7070/DSN: (312) 647-7070.
(2) Commands must ensure documentation of influenza vaccine
administration is coded to accurately reflect the type of vaccine given.
(3) Afloat units will enter influenza immunizations into the
Shipboard Automated Medical System (SAMS) or the Theater Medical Information
Program Maritime (TMIP-M).
(4) All personnel who receive the vaccination from a retail network
pharmacy must provide documentation of vaccination no later than the next
work day (or next drill day for Reserve personnel) to ensure compliance is
appropriately recorded in MRRS and the EHR.
k. Influenza Vaccination Timeline
(1) Due to the risk of infection transmission within the unit and
impact on operations, it is imperative that the vaccine be given with as
minimal delay as possible. Active duty operational units have 72 hours
(three work days) following receipt of the vaccine to administer and document
vaccination. The 72-hour requirement begins immediately only if the
temperature monitor is in "no alarm" status upon receipt; if in "alarmed"
status the timed requirement begins once / if the vaccine is cleared for use
by DLA-TSM. If the 72-hour requirement cannot be met, unit situation reports
will be submitted to the respective Immediate Superior in Command and Type
Commanders. Situation reports are not required if the temperature monitor is
in alarmed status and the unit is awaiting disposition from DLA-TSM.
(2) As Reserve Component Command schedules vary, NAVMEDLOGCOM and DLA
-TSM will coordinate to make every effort for the vaccine to arrive the week
of a drill weekend. Units have one drill weekend following receipt of the
vaccine to administer and document vaccination if the temperature monitor is
in a "no alarm" status. If in "alarmed" status, the timed requirement begins
once/if the vaccine is cleared for use by DLA-TSM.
l. Navy Goals and Performance Standards
(1) To ensure force medical readiness before peak influenza season,
all Navy operational units and Navy Medicine Readiness and Training Commands
and Units (NMRTC/Us) will administer the 2020-2021 influenza vaccination to
exceed the 90 percent vaccination goal by 15 December 2020 for Active and
Reserve Components. Complete vaccine access will be provided for the entire
Navy family (including dependents, other beneficiaries, and DON
civilians). Active coordination between command leadership, public affairs
officers, and medical personnel is necessary to achieve success.
(2) Influenza Vaccination Performance Standards. The following goals
will be monitored:
(a) Navy VIALS reports 100 percent of shipped vaccine received
onboard by fleet and Navy units by 1 December 2020.
(b) MRRS reports 90 percent of Active and Reserve Component
vaccinated by 15 December 2020. Commands will coordinate with the servicing
MTF to align command-wide vaccinations with Navy vaccination goals. Medical
personnel at servicing MTFs will promptly report vaccinations in MRRS.
m. Vaccine administration and COVID-19
(1) The COVID-19 pandemic is not a contraindication for
administration of the influenza vaccination and every effort should be made
to deliver the vaccine as quickly as possible to eligible Service members.
(2) If a SARS-CoV-2 vaccine becomes available during the seasonal
influenza vaccination period, commands will follow instructions from BUMED,
supporting MTFs, and NMRTC/Us. Expect promulgation of further guidance via
NAVADMIN if a SARS-CoV-2 vaccine is approved and purchased by DoD.
3. Released by Mr. Andrew S. Haeuptle, Director, Navy Staff.//